Abstract
Transcatheter aortic valve implantation for bicuspid aortic valve stenosis (BAVS) is controversial, as its unfavorable anatomy may lead to device dislocation or malfunctioning. If device failure occurs, the bailout intervention can be more complex and technically challenging. We here report a unique case of late migration of a CoreValve (Medtronic, MN) implanted in a patient with BAVS, who was successfully treated with elective valve-in-valve implantation using the first valve as a firm scaffold after waiting for it to adhere at the migrated position. This new strategy may represent a useful salvage option for some patients with prosthesis migration.
Keywords:
aortic valve disease; structural heart disease intervention; transcatheter valve implantation.
© 2015 Wiley Periodicals, Inc.
MeSH terms
-
Aged, 80 and over
-
Aortic Valve / abnormalities*
-
Aortic Valve / physiopathology
-
Aortic Valve Stenosis / diagnosis
-
Aortic Valve Stenosis / etiology
-
Aortic Valve Stenosis / physiopathology
-
Aortic Valve Stenosis / therapy*
-
Balloon Valvuloplasty
-
Bicuspid Aortic Valve Disease
-
Bioprosthesis*
-
Cardiac Catheterization / instrumentation*
-
Female
-
Foreign-Body Migration / diagnosis
-
Foreign-Body Migration / etiology
-
Foreign-Body Migration / therapy*
-
Heart Valve Diseases / complications*
-
Heart Valve Diseases / diagnosis
-
Heart Valve Diseases / physiopathology
-
Heart Valve Prosthesis Implantation / adverse effects
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis Implantation / methods
-
Heart Valve Prosthesis*
-
Humans
-
Multidetector Computed Tomography
-
Prosthesis Design
-
Radiography, Interventional
-
Time Factors
-
Treatment Outcome